EASTERN COOPERATIVE ONCOLOGY GROUP

东方肿瘤合作组

• 批准号: 6375564
• 负责人: thomas matthew habermann
• 金额: $ 21.89万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-06-01 至 2004-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6375564
• 关键词: AIDS; antineoplastics; biological response modifiers; bone marrow transplantation; brain neoplasms; breast neoplasms; cancer prevention; clinical research; clinical trials; combination cancer therapy; combination chemotherapy; cooperative study; fluorescent in situ hybridization; gastrointestinal neoplasms; gene therapy; head /neck neoplasm; health behavior; human subject; human therapy evaluation; leukemia; lymphoma; melanoma; minimal residual disease; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer pharmacology; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; neoplasm /cancer vaccine; nucleic acid sequence; pathology; prognosis; reproductive system neoplasm; thorax neoplasm; tissue resource /registry; urinary tract neoplasms

The purpose of this grant application is to support Mayo Clinic membership in the Eastern Cooperative Oncology Group (ECOG). The goals are directed toward a greater understanding of cancer, a better understanding of cancer-related problems, development of improved cancer treatment programs, and improved cancer-patient survival. Mayo Clinic has the resources, personnel, facilities, a patient population to facilitate strong contributions to the research programs of the Eastern Cooperative Oncology Group. With the continued growth and development of the Mayo medical practice, we would anticipate significant protocol entry and scientific contribution. The ECOG affiliation and treatment program which have evolved provide major benefits to Mayo Clinic, its investigators, regional cancer programs, and the large group of cancer patients who are involved in these research activities. The specific aims of this grant proposal are to support the following aspects of Mayo Clinic ECOG research activities including: 1. Patient accrual to group-wide ECOG cancer treatment protocols. 2. The evaluation of new protocol design and treatment regimens to provide group-wide ECOG Phase II and II cancer treatment protocols. 3. Coordination of, and participation in, adjunctive laboratory-based correlative studies in association with ECOG cancer treatment protocols. 4. Participation in disease-specific activities and such administrative roles as might be appointed and appropriate.

本补助金申请的目的是支持马约诊所成为东部肿瘤协作组（ECOG）的成员。 这些目标是为了更好地了解癌症，更好地了解癌症相关问题，开发改进的癌症治疗方案，并提高癌症患者的生存率。 马约诊所拥有资源、人员、设施和患者群体，可以为东部肿瘤协作组的研究项目做出强有力的贡献。 随着马约医疗实践的持续增长和发展，我们预计会有重大的方案进入和科学贡献。 已经发展的ECOG附属机构和治疗计划为马约诊所、其研究者、区域癌症项目和参与这些研究活动的大量癌症患者提供了主要益处。 该资助提案的具体目的是支持马约诊所ECOG研究活动的以下方面，包括：1. 全组ECOG癌症治疗方案的患者招募。 2. 评价新方案设计和治疗方案，以提供全组ECOG II期和II期癌症治疗方案。 3. 协调和参与与ECOG癌症治疗方案相关的连续性实验室相关研究。 4. 参与针对特定疾病的活动，并担任可能任命的适当行政职务。